Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-19-048049
Filing Date
2019-02-22
Accepted
2019-02-22 13:21:02
Documents
2
Group Members
ARIX BIOSCIENCE HOLDINGS LTDMARK CHIN

Document Format Files

Seq Description Document Type Size
1 SC 13D d669723dsc13d.htm SC 13D 100977
2 EX-99.1 d669723dex991.htm EX-99.1 4142
  Complete submission text file 0001193125-19-048049.txt   106633
Mailing Address 20 BERKELEY SQUARE LONDON X0 W1J 6EQ
Business Address 20 BERKELEY SQUARE LONDON X0 W1J 6EQ 44(0)20 7290 1050
Arix Bioscience plc (Filed by) CIK: 0001700449 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
Type: SC 13D

Mailing Address 4000 SHORELINE CT #250 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE CT #250 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Subject) CIK: 0001708493 (see all company filings)

EIN.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90935 | Film No.: 19625011
SIC: 2836 Biological Products, (No Diagnostic Substances)